Galvus, A DPP-4 Inhibitor And Incretin Enhancer Tablet, May Offer New Hope Of Better Diabetes Control To Elderly Patients

Mon, 25 Sep 2006 07:00 PM EST

... Elderly patients with Type 2 diabetes who find it hard to control their blood sugar with tablets are especially likely to benefit from a new once-daily oral drug in development, say diabetes researchers. Galvus (vildagliptin) is one of the first drugs in a new class that controls diabetes by boosting hormones called incretins which help regulate blood sugar. [click link for full article] ...